John P A Ioannidis (John Pa Ioannidis, John P Ioannidis, John Ioannidis)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 111

Top Venues

European journal of clinical investigation

medRxiv : the preprint server for health sciences

Royal Society open science

PLoS biology

This page only lists publications with an associated author ORCID identifier.

Publications

Taulant Muka, Joshua J X Li, Sahar J Farahani, John P A Ioannidis
An umbrella review of systematic reviews on the impact of the COVID-19 pandemic on cancer prevention and management, and patient needs. eLife 12 (2023)
John P A Ioannidis, Francesco Zonta, Michael Levitt
Variability in excess deaths across countries with different vulnerability during 2020-2023. medRxiv : the preprint server for health sciences (2023)
Emmanuel A Zavalis, Anaïs Rameau, Anirudh Saraswathula, Joachim Vist, Ewoud Schuit, John P A Ioannidis
Availability of evidence and comparative effectiveness for surgical versus drug interventions: an overview of systematic reviews. medRxiv : the preprint server for health sciences (2023)
Ulrich Robert Mansmann, Clara Locher, Fabian Prasser, Tracey L Weissberger, Ulrich Sax, Martin Posch, Evelyne Decullier, Ioana A Cristea, Thomas P A Debray, Leonhard Held, David Moher, John P A Ioannidis, Joseph R Ross, Christian Ohmann, Florian Naudet
Implementing clinical trial data sharing requires training a new generation of biomedical researchers. Nature medicine 29 (2) (2023)
John P A Ioannidis, Francesco Zonta, Michael Levitt
Estimates of COVID-19 deaths in Mainland China after abandoning zero COVID policy. European journal of clinical investigation (2023)
John P A Ioannidis, Francesco Zonta, Michael Levitt
Estimates of COVID-19 deaths in Mainland China after abandoning zero COVID policy. European journal of clinical investigation 53 (4) (2023)
Stylianos Serghiou, Cathrine Axfors, John P A Ioannidis
Lessons learnt from registration of biomedical research. Nature human behaviour (2023)
John P A Ioannidis, Francesco Zonta, Michael Levitt
Flaws and uncertainties in pandemic global excess death calculations. European journal of clinical investigation (2023)
Kelly D Cobey, Christophe A Fehlmann, Marina Christ Franco, Ana Patricia Ayala, Lindsey Sikora, Danielle B Rice, Chenchen Xu, John P A Ioannidis, Manoj M Lalu, Alixe Ménard, Andrew Neitzel, Bea Nguyen, Nino Tsertsvadze, David Moher
Epidemiological characteristics and prevalence rates of research reproducibility across disciplines: a scoping review of articles published in 2018-2019. eLife 12 (2023)
Marc Raynaud, Solaf Al-Awadhi, Kevin Louis, Huanxi Zhang, Xiaojun Su, Valentin Goutaudier, Jiali Wang, Zeynep Demir, Yongcheng Wei, Agathe Truchot, Antoine Bouquegneau, Arnaud Del Bello, Élodie Bailly, Yannis Lombardi, Mehdi Maanaoui, Alessia Giarraputo, Sofia Naser, Gillian Divard, Olivier Aubert, Mohammad Hassan Murad, Changxi Wang, Longshan Liu, Oriol Bestard, Maarten Naesens, John J Friedewald, Carmen Lefaucheur, Leonardo V Riella, Gary Stephen Collins, John P A Ioannidis, Alexandre Loupy
Prognostic Biomarkers in Kidney Transplantation: a Systematic Review and Critical Appraisal. Journal of the American Society of Nephrology : JASN (2023)
John P A Ioannidis, Francesco Zonta, Michael Levitt
Variability in excess deaths across countries with different vulnerability during 2020-2023. Proceedings of the National Academy of Sciences of the United States of America 120 (49) (2023)
Andrea Saltelli, Joachimh P Sturmberg, Daniel Sarewitz, John P A Ioannidis
What did COVID-19 really teach us about science, evidence and society? Journal of evaluation in clinical practice (2023)
John P A Ioannidis, Francesco Zonta, Michael Levitt
Estimates of COVID-19 deaths in Mainland China after abandoning zero COVID policy. European journal of clinical investigation 53 (4) (2023)
John P A Ioannidis
Inverse publication reporting bias favouring null, negative results. BMJ evidence-based medicine (2023)
John P A Ioannidis, Francesco Zonta, Michael Levitt
Estimates of COVID-19 deaths in Mainland China after abandoning zero COVID policy. medRxiv : the preprint server for health sciences (2023)
Soo Young Hwang, Dong-Keon Yon, Seung-Won Lee, Min Seo Kim, Jong Yeob Kim, Lee Smith, Ai Koyanagi, Marco Solmi, André F Carvalho, Eun Young Kim, Youn Ho Shin, John P A Ioannidis
Causes for Retraction in the Biomedical Literature: A Systematic Review of Studies of Retraction Notices. Journal of Korean medical science 38 (41) (2023)
Robert T Thibault, Marton Kovacs, Tom E Hardwicke, Alexandra Sarafoglou, John P A Ioannidis, Marcus R Munafo
Reducing bias in secondary data analysis via an Explore and Confirm Analysis Workflow (ECAW): a proposal and survey of observational researchers. Royal Society open science 10 (10) (2023)
John P A Ioannidis, Francesco Zonta, Michael Levitt
Estimates of COVID-19 deaths in Mainland China after abandoning zero COVID policy. medRxiv : the preprint server for health sciences (2023)
Alena Chalupka, Lukas Richter, Ali Chakeri, Ziad El-Khatib, Verena Theiler-Schwetz, Christian Trummer, Robert Krause, Peter Willeit, Bernhard Benka, John P A Ioannidis, Stefan Pilz
Effectiveness of a fourth SARS-CoV-2 vaccine dose in previously infected individuals from Austria. European journal of clinical investigation (2023)
Andrew Nepomuceno, Hilary Bayer, John P A Ioannidis
Impact of major awards on the subsequent work of their recipients. Royal Society open science 10 (8) (2023)
Janneke van 't Hooft, Charlotte E van Dijk, Cathrine Axfors, Zarko Alfirevic, Martijn A Oudijk, Khalid Saeed Khan, Ben-Willem J Mol, Patrick M M Bossuyt, John P A Ioannidis
Assessing the usefulness of randomised trials in obstetrics and gynaecology. BJOG : an international journal of obstetrics and gynaecology (2023)
John P A Ioannidis, Francesco Zonta, Michael Levitt
Estimates of COVID-19 deaths in Mainland China after abandoning zero COVID policy. medRxiv : the preprint server for health sciences (2023)
John P A Ioannidis, Francesco Zonta, Michael Levitt
Variability in excess deaths across countries with different vulnerability during 2020-2023. medRxiv : the preprint server for health sciences (2023)
Yiannis Manoussopoulos, Cleo Anastassopoulou, John P A Ioannidis, Athanassios Tsakris
Paired associated SARS-CoV-2 spike variable positions: a network analysis approach to emerging variants. mSystems (2023)
Ulrich Robert Mansmann, Clara Locher, Fabian Prasser, Tracey L Weissberger, Ulrich Sax, Martin Posch, Evelyne Decullier, Ioana A Cristea, Thomas P A Debray, Leonhard Held, David Moher, John P A Ioannidis, Joseph R Ross, Christian Ohmann, Florian Naudet
Implementing clinical trial data sharing requires training a new generation of biomedical researchers. Nature medicine 29 (2) (2023)
John P A Ioannidis, Francesco Zonta, Michael Levitt
Variability in excess deaths across countries with different vulnerability during 2020-2023. medRxiv : the preprint server for health sciences (2023)
Ulrich Robert Mansmann, Clara Locher, Fabian Prasser, Tracey L Weissberger, Ulrich Sax, Martin Posch, Evelyne Decullier, Ioana A Cristea, Thomas P A Debray, Leonhard Held, David Moher, John P A Ioannidis, Joseph R Ross, Christian Ohmann, Florian Naudet
Implementing clinical trial data sharing requires training a new generation of biomedical researchers. Nature medicine (2023)
John P A Ioannidis
Prolific non-research authors in high impact scientific journals: meta-research study. Scientometrics 128 (5) (2023)
Emmanuel A Zavalis, Anaïs Rameau, Anirudh Saraswathula, Joachim Vist, Ewoud Schuit, John P A Ioannidis
Availability of evidence and comparative effectiveness for surgical versus drug interventions: an overview of systematic reviews. medRxiv : the preprint server for health sciences (2023)
Michael Levitt, Francesco Zonta, John P A Ioannidis
Excess death estimates from multiverse analysis in 2009-2021. European journal of epidemiology (2023)
Stylianos Serghiou, Cathrine Axfors, John P A Ioannidis
Lessons learnt from registration of biomedical research. Nature human behaviour 7 (1) (2023)
John P A Ioannidis
Prolific non-research authors in high impact scientific journals: meta-research study. Scientometrics 128 (5) (2023)
Kat Kolaski, Lynne Romeiser Logan, John P A Ioannidis
Guidance to Best Tools and Practices for Systematic Reviews. JBJS reviews 11 (6) (2023)
John P A Ioannidis, Francesco Zonta, Michael Levitt
Estimates of COVID-19 deaths in Mainland China after abandoning zero COVID policy. European journal of clinical investigation (2023)
John P A Ioannidis, Kevin W Boyack, Thomas A Collins, Jeroen Baas
Gender imbalances among top-cited scientists across scientific disciplines over time through the analysis of nearly 5.8 million authors. PLoS biology 21 (11) (2023)
John P A Ioannidis, Francesco Zonta, Michael Levitt
Estimates of COVID-19 deaths in Mainland China after abandoning zero COVID policy. medRxiv : the preprint server for health sciences (2023)
John P A Ioannidis, Zacharias Maniadis
Quantitative research assessment: using metrics against gamed metrics. Internal and emergency medicine (2023)
Ulrich Robert Mansmann, Clara Locher, Fabian Prasser, Tracey L Weissberger, Ulrich Sax, Martin Posch, Evelyne Decullier, Ioana A Cristea, Thomas P A Debray, Leonhard Held, David Moher, John P A Ioannidis, Joseph R Ross, Christian Ohmann, Florian Naudet
Implementing clinical trial data sharing requires training a new generation of biomedical researchers. Nature medicine 29 (2) (2023)
John P A Ioannidis, Francesco Zonta, Michael Levitt
Estimates of COVID-19 deaths in Mainland China after abandoning zero COVID policy. European journal of clinical investigation (2023)
John P A Ioannidis, Zacharias Maniadis
In defense of quantitative metrics in researcher assessments. PLoS biology 21 (12) (2023)
Kim Boesen, John P A Ioannidis
Medical advertisements and scientific journals: Time for editors and publishers to take a stance. Journal of evaluation in clinical practice (2023)
Stylianos Serghiou, Cathrine Axfors, John P A Ioannidis
Lessons learnt from registration of biomedical research. Nature human behaviour 7 (1) (2023)
John P A Ioannidis
Science with or without statistics: Discover-generalize-replicate? Discover-replicate-generalize? The Behavioral and brain sciences 45 (2022)
John P A Ioannidis, Francesco Zonta, Michael Levitt
Estimates of COVID-19 deaths in Mainland China after abandoning zero COVID policy. medRxiv : the preprint server for health sciences (2022)
John P A Ioannidis
Estimating conditional vaccine effectiveness. European journal of epidemiology 37 (9) (2022)
Josefína Weinerová, Denes Szucs, John P A Ioannidis
Published correlational effect sizes in social and developmental psychology. Royal Society open science 9 (12) (2022)
Cathrine Axfors, John P A Ioannidis
Infection fatality rate of COVID-19 in community-dwelling elderly populations. European journal of epidemiology 37 (3) (2022)
Marcel Ballin, John P A Ioannidis, Jonathan Bergman, Miia Kivipelto, Anna Nordström, Peter Nordström
Time-varying risk of death after SARS-CoV-2 infection in Swedish long-term care facility residents: a matched cohort study. BMJ open 12 (11) (2022)
Lazaros Belbasis, Vanesa Bellou, John P A Ioannidis
Conducting umbrella reviews. BMJ medicine 1 (1) (2022)
Vinay Prasad, John P A Ioannidis
Constructive and obsessive criticism in science. European journal of clinical investigation 52 (11) (2022)
Josefína Weinerová, Denes Szucs, John P A Ioannidis
Published correlational effect sizes in social and developmental psychology. Royal Society open science 9 (12) (2022)
Xiaoting Shi, Haoran Zhuo, Yuxuan Du, Kate Nyhan, John P A Ioannidis, Joshua D Wallach
Environmental risk factors for non-Hodgkin's lymphoma: umbrella review and comparison of meta-analyses of summary and individual participant data. BMJ medicine 1 (1) (2022)
John P A Ioannidis, Eran Bendavid, Maia Salholz-Hillel, Kevin W Boyack, Jeroen Baas
Massive covidization of research citations and the citation elite. Proceedings of the National Academy of Sciences of the United States of America 119 (28) (2022)
Josefína Weinerová, Denes Szucs, John P A Ioannidis
Published correlational effect sizes in social and developmental psychology. Royal Society open science 9 (12) (2022)
Xiaoting Shi, Haoran Zhuo, Yuxuan Du, Kate Nyhan, John P A Ioannidis, Joshua D Wallach
Environmental risk factors for non-Hodgkin's lymphoma: umbrella review and comparison of meta-analyses of summary and individual participant data. BMJ medicine 1 (1) (2022)
John P A Ioannidis, Francesco Zonta, Michael Levitt
Estimates of COVID-19 deaths in Mainland China after abandoning zero COVID policy. medRxiv : the preprint server for health sciences (2022)
Michael Levitt, Francesco Zonta, John P A Ioannidis
Excess death estimates from multiverse analysis in 2009-2021. medRxiv : the preprint server for health sciences (2022)
Josefína Weinerová, Denes Szucs, John P A Ioannidis
Published correlational effect sizes in social and developmental psychology. Royal Society open science 9 (12) (2022)
Lazaros Belbasis, Vanesa Bellou, John P A Ioannidis
Conducting umbrella reviews. BMJ medicine 1 (1) (2022)
John P A Ioannidis, Francesco Zonta, Michael Levitt
Estimates of COVID-19 deaths in Mainland China after abandoning zero COVID policy. medRxiv : the preprint server for health sciences (2022)
Josefína Weinerová, Denes Szucs, John P A Ioannidis
Published correlational effect sizes in social and developmental psychology. Royal Society open science 9 (12) (2022)
Julian Hirt, Perrine Janiaud, Viktoria Luise Gloy, Stefan Schandelmaier, Tiago V Pereira, Despina Contopoulos-Ioannidis, Steven N Goodman, John P A Ioannidis, Klaus Munkholm, Lars G Hemkens
Robustness of reported postacute health outcomes in children with SARS-CoV-2 infection: a systematic review. Archives of disease in childhood (2022)
Josefína Weinerová, Denes Szucs, John P A Ioannidis
Published correlational effect sizes in social and developmental psychology. Royal Society open science 9 (12) (2022)
John P A Ioannidis
Citation impact and social media visibility of Great Barrington and John Snow signatories for COVID-19 strategy. BMJ open 12 (2) (2022)
John P A Ioannidis
Factors influencing estimated effectiveness of COVID-19 vaccines in non-randomised studies. BMJ evidence-based medicine 27 (6) (2022)
Tom E Hardwicke, Robert T Thibault, Jessica E Kosie, Loukia Tzavella, Theiss Bendixen, Sarah A Handcock, Vivian E Köneke, John P A Ioannidis
Post-publication critique at top-ranked journals across scientific disciplines: a cross-sectional assessment of policies and practice. Royal Society open science 9 (8) (2022)
Emmanuel A Zavalis, John P A Ioannidis
A meta-epidemiological assessment of transparency indicators of infectious disease models. PloS one 17 (10) (2022)
Josefína Weinerová, Denes Szucs, John P A Ioannidis
Published correlational effect sizes in social and developmental psychology. Royal Society open science 9 (12) (2022)
John P A Ioannidis
The end of the COVID-19 pandemic. European journal of clinical investigation 52 (6) (2022)
John P A Ioannidis, Francesco Zonta, Michael Levitt
Estimates of COVID-19 deaths in Mainland China after abandoning zero COVID policy. medRxiv : the preprint server for health sciences (2022)
John P A Ioannidis
Systematic reviews for basic scientists: a different beast. Physiological reviews 103 (1) (2022)
Stefan Pilz, John P A Ioannidis
Does natural and hybrid immunity obviate the need for frequent vaccine boosters against SARS-CoV-2 in the endemic phase? European journal of clinical investigation (2022)
H Felix Fischer, Brooke Levis, Carl F Falk, Ying Sun, John P A Ioannidis, Pim Cuijpers, Ian Shrier, Andrea Benedetti, Brett D Thombs, null null
Comparison of different scoring methods based on latent variable models of the PHQ-9: an individual participant data meta-analysis. Psychological medicine (2021)
Stylianos Serghiou, Rebecca M Marton, John P A Ioannidis
Media and social media attention to retracted articles according to Altmetric. PloS one 16 (5) (2021)
Xue Li, Stefano Celotto, Damiano Pizzol, Danijela Gasevic, Meng-Meng Ji, Tommaso Barnini, Marco Solmi, Brendon Stubbs, Lee Smith, Guillermo F López Sánchez, Gabriella Pesolillo, Zengli Yu, Ioanna Tzoulaki, Evropi Theodoratou, John P A Ioannidis, Nicola Veronese, Jacopo Demurtas
Metformin and health outcomes: An umbrella review of systematic reviews with meta-analyses. European journal of clinical investigation 51 (7) (2021)
John P A Ioannidis
Nutrition and Health: Setting Realistic Expectations and Changing Research Targets. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 36 (2) (2021)
Florian Naudet, Maximilian Siebert, Claude Pellen, Jeanne Fabiola Gaba, Cathrine Axfors, Ioana Alina Cristea, Valentin Danchev, Ulrich Robert Mansmann, Christian Ohmann, Joshua D Wallach, David Moher, John P A Ioannidis
Medical journal requirements for clinical trial data sharing: Ripe for improvement. PLoS medicine 18 (10) (2021)
John P A Ioannidis
Reconciling estimates of global spread and infection fatality rates of COVID-19: An overview of systematic evaluations. European journal of clinical investigation 51 (5) (2021)
John P A Ioannidis, Alangoya Tezel, Reshma Jagsi
Overall and COVID-19-specific citation impact of highly visible COVID-19 media experts: bibliometric analysis. BMJ open 11 (10) (2021)
Eran Bendavid, Christopher Oh, Jay Bhattacharya, John P A Ioannidis
Assessing mandatory stay-at-home and business closure effects on the spread of COVID-19. European journal of clinical investigation 51 (4) (2021)
Stylianos Serghiou, Despina G Contopoulos-Ioannidis, Kevin W Boyack, Nico Riedel, Joshua D Wallach, John P A Ioannidis
Assessment of transparency indicators across the biomedical literature: How open is open? PLoS biology 19 (3) (2021)
Eran Bendavid, Christopher Oh, Jay Bhattacharya, John P A Ioannidis
Authors Response to Letters to the editor regarding: 'Assessing mandatory stay- At- Home and business closure effects on the spread of COVID- 19'. European journal of clinical investigation 51 (6) (2021)
Cathrine Axfors, Andreas Michael Schmitt, Perrine Janiaud, Janneke van 't Hooft, Sherief M Abd-Elsalam, Ehab F Abdo, Benjamin S Abella, Javed Akram, Ravi K Amaravadi, Derek C Angus, Yaseen M Arabi, Shehnoor Azhar, Lindsey R Baden, Arthur W Baker, Leila Belkhir, Thomas Lars Benfield, Marvin A H Berrevoets, Cheng-Pin Chen, Tsung-Chia Chen, Shu-Hsing Cheng, Chien-Yu Cheng, Wei-Sheng Chung, Yehuda Z Cohen, Lisa N Cowan, Olav Dalgard, Fernando F de Almeida E Val, Marcus Vinícius Guimarães de Lacerda, Gisely C de Melo, Lennie P G Derde, Vincent Dubee, Anissa Elfakir, Anthony C Gordon, Carmen M Hernandez-Cardenas, Thomas E Hills, Andy I M Hoepelman, Yi-Wen Huang, Bruno Igau, Ronghua Jin, Felipe Jurado-Camacho, Khalid S Khan, Peter G Kremsner, Benno Kreuels, Cheng-Yu Kuo, Thuy Le, Yi-Chun Lin, Wu-Pu Lin, Tse-Hung Lin, Magnus Nakrem Lyngbakken, Colin McArthur, Bryan J McVerry, Patricia Meza-Meneses, Wuelton M Monteiro, Susan C Morpeth, Ahmad Mourad, Mark J Mulligan, Srinivas Murthy, Susanna Naggie, Shanti Narayanasamy, Alistair Nichol, Lewis A Novack, Sean M O'Brien, Nwora Lance Okeke, Léna Perez, Rogelio Perez-Padilla, Laurent Perrin, Arantxa Remigio-Luna, Norma Eréndira Rivera-Martínez, Frank W Rockhold, Sebastian Rodriguez-Llamazares, Robert Rolfe, Rossana Rosa, Helge Røsjø, Vanderson de Souza Sampaio, Todd B Seto, Muhammad Shahzad, Shaimaa Soliman, Jason E Stout, Ireri Thirion-Romero, Andrea B Troxel, Ting-Yu Tseng, Nicholas A Turner, Robert J Ulrich, Stephen R Walsh, Steve A Webb, Jesper M Weehuizen, Maria Velinova, Hon-Lai Wong, Rebekah Wrenn, Fernando Godinho Zampieri, Xinbo Zhou, David Moher, Steven N Goodman, John P A Ioannidis, Lars G Hemkens
Author Correction: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials. Nature communications 12 (1) (2021)
Esben Malm, Sabrina Mai Nielsen, Johannes Berg, John P A Ioannidis, Daniel Furst, Josef S Smolen, Peter C Taylor, Lars Erik Kristensen, Simon Tarp, Torkell J Ellingsen, Robin Christensen
Risk of harm in synthetic and biological intervention trials in patients with inflammatory arthritis: protocol for a metaepidemiological study focusing on contextual factors. BMJ open 11 (9) (2021)
John P A Ioannidis, Maia Salholz-Hillel, Kevin W Boyack, Jeroen Baas
The rapid, massive growth of COVID-19 authors in the scientific literature. Royal Society open science 8 (9) (2021)
Cathrine Axfors, Andreas Michael Schmitt, Perrine Janiaud, Janneke van 't Hooft, Sherief M Abd-Elsalam, Ehab F Abdo, Benjamin S Abella, Javed Akram, Ravi K Amaravadi, Derek C Angus, Yaseen M Arabi, Shehnoor Azhar, Lindsey R Baden, Arthur W Baker, Leila Belkhir, Thomas Lars Benfield, Marvin A H Berrevoets, Cheng-Pin Chen, Tsung-Chia Chen, Shu-Hsing Cheng, Chien-Yu Cheng, Wei-Sheng Chung, Yehuda Z Cohen, Lisa N Cowan, Olav Dalgard, Fernando F de Almeida E Val, Marcus Vinícius Guimarães de Lacerda, Gisely C de Melo, Lennie P G Derde, Vincent Dubee, Anissa Elfakir, Anthony C Gordon, Carmen M Hernandez-Cardenas, Thomas E Hills, Andy I M Hoepelman, Yi-Wen Huang, Bruno Igau, Ronghua Jin, Felipe Jurado-Camacho, Khalid S Khan, Peter G Kremsner, Benno Kreuels, Cheng-Yu Kuo, Thuy Le, Yi-Chun Lin, Wu-Pu Lin, Tse-Hung Lin, Magnus Nakrem Lyngbakken, Colin McArthur, Bryan J McVerry, Patricia Meza-Meneses, Wuelton M Monteiro, Susan C Morpeth, Ahmad Mourad, Mark J Mulligan, Srinivas Murthy, Susanna Naggie, Shanti Narayanasamy, Alistair Nichol, Lewis A Novack, Sean M O'Brien, Nwora Lance Okeke, Léna Perez, Rogelio Perez-Padilla, Laurent Perrin, Arantxa Remigio-Luna, Norma Eréndira Rivera-Martínez, Frank W Rockhold, Sebastian Rodriguez-Llamazares, Robert Rolfe, Rossana Rosa, Helge Røsjø, Vanderson de Souza Sampaio, Todd B Seto, Muhammad Shahzad, Shaimaa Soliman, Jason E Stout, Ireri Thirion-Romero, Andrea B Troxel, Ting-Yu Tseng, Nicholas A Turner, Robert J Ulrich, Stephen R Walsh, Steve A Webb, Jesper M Weehuizen, Maria Velinova, Hon-Lai Wong, Rebekah Wrenn, Fernando Godinho Zampieri, Xinbo Zhou, David Moher, Steven N Goodman, John P A Ioannidis, Lars G Hemkens
Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials. Nature communications 12 (1) (2021)
John P A Ioannidis
Precision shielding for COVID-19: metrics of assessment and feasibility of deployment. BMJ global health 6 (1) (2021)
John P A Ioannidis
Benefit of COVID-19 vaccination accounting for potential risk compensation. NPJ vaccines 6 (1) (2021)
Stefan Pilz, Ali Chakeri, John P A Ioannidis, Lukas Richter, Verena Theiler-Schwetz, Christian Trummer, Robert Krause, Franz Allerberger
SARS-CoV-2 re-infection risk in Austria. European journal of clinical investigation 51 (4) (2021)
Perrine Janiaud, Arnav Agarwal, Ioanna Tzoulaki, Evropi Theodoratou, Konstantinos K Tsilidis, Evangelos Evangelou, John P A Ioannidis
Validity of observational evidence on putative risk and protective factors: appraisal of 3744 meta-analyses on 57 topics. BMC medicine 19 (1) (2021)
John P A Ioannidis
COVID-19 vaccination in children and university students. European journal of clinical investigation 51 (11) (2021)
Kim Boesen, Peter C Gøtzsche, John P A Ioannidis
EMA and FDA psychiatric drug trial guidelines: assessment of guideline development and trial design recommendations. Epidemiology and psychiatric sciences 30 (2021)
Joshua R Lewis, Trudy G Voortman, John P A Ioannidis
Evaluating and Strengthening the Evidence for Nutritional Bone Research: Ready to Break New Ground? Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 36 (2) (2021)
Leonardo Villani, Roberta Pastorino, Walter Ricciardi, John P A Ioannidis, Stefania Boccia
Inverse correlates of COVID-19 mortality across European countries during the first versus subsequent waves. BMJ global health 6 (8) (2021)
John P A Ioannidis
Coronavirus disease 2019: The harms of exaggerated information and non-evidence-based measures. European journal of clinical investigation 50 (4) (2020)
Ioana Alina Cristea, Florian Naudet, John P A Ioannidis
Preserving equipoise and performing randomised trials for COVID-19 social distancing interventions. Epidemiology and psychiatric sciences 29 (2020)
John P A Ioannidis
Global perspective of COVID-19 epidemiology for a full-cycle pandemic. European journal of clinical investigation 50 (12) (2020)
John P A Ioannidis, Ioana Alina Cristea, Kevin W Boyack
Work honored by Nobel prizes clusters heavily in a few scientific fields. PloS one 15 (7) (2020)
John P A Ioannidis, Kevin W Boyack, Jeroen Baas
Updated science-wide author databases of standardized citation indicators. PLoS biology 18 (10) (2020)
Peter Tugwell, Vivian Andrea Welch, Sathya Karunananthan, Lara J Maxwell, Elie A Akl, Marc T Avey, Zulfiqar A Bhutta, Melissa C Brouwers, Jocalyn P Clark, Sophie Cook, Luis Gabriel Cuervo, Janet Agnes Curran, Elizabeth Tanjong Ghogomu, Ian D Graham, Jeremy M Grimshaw, Brian Hutton, John P A Ioannidis, Zoe Jordan, Janet Elizabeth Jull, Elizabeth Kristjansson, Etienne V Langlois, Julian Little, Anne Lyddiatt, Janet E Martin, Ana Marusic, Lawrence Mbuagbaw, David Moher, Rachael Lisa Morton, Mona Nasser, Matthew J Page, Jordi Pardo Pardo, Jennifer Petkovic, Mark Petticrew, Terri Pigott, Kevin Pottie, Gabriel Rada, Tamara Rader, Alison Y Riddle, Hannah Rothstein, Holger J Schüneman, Larissa Shamseer, Beverley J Shea, Rosiane Simeon, Konstantinos C Siontis, Maureen Smith, Karla Soares-Weiser, Walter P Wodchis, David Tovey, Brigitte Vachon, Jeffrey C Valentine, Rebecca Villemaire, Peter Walker, Laura Weeks, George Wells, David B Wilson, Howard White
When to replicate systematic reviews of interventions: consensus checklist. BMJ (Clinical research ed.) 370 (2020)

John P A Ioannidis.css-eqlu8i{font-size:small;padding-left:4px;} (John Pa Ioannidis, John P Ioannidis, John Ioannidis)

Publication Activity (10 Years)

Top Topics

Top Venues

John P A Ioannidis (John Pa Ioannidis, John P Ioannidis, John Ioannidis)